MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-07-2026
Soleno Therapeutics Total Shareholders Equity 2011-2026 | SLNO
Annual Total Shareholders Equity Soleno Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 450 M | 245 M | 158 M | 10.3 M | 17.8 M | 45.5 M | 14.9 M | 30.4 M | 26.8 M | 3.44 M | 3.22 M | -11.2 M | -37.9 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 450 M | -37.9 M | 73.6 M |
Quarterly Total Shareholders Equity Soleno Therapeutics
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 496 M | 495 M | 240 M | 232 M | 245 M | 265 M | 281 M | 143 M | 158 M | 23.2 M | 12.4 M | 2.64 M | 10.3 M | 15.2 M | 20.3 M | 26.5 M | 17.8 M | 20.2 M | 27.4 M | 37.6 M | 45.5 M | 45.5 M | 45.5 M | 45.5 M | 14.9 M | 14.9 M | 14.9 M | 14.9 M | 30.4 M | 30.4 M | 30.4 M | 30.4 M | 26.8 M | 26.8 M | 26.5 M | 26.5 M | 3.44 M | 3.44 M | 3.44 M | 3.44 M | 3.22 M | 3.22 M | 3.22 M | 3.22 M | -11.2 M | -11.2 M | -11.2 M | -11.2 M | -34.2 M | -37.9 M | - | - | -34.2 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 496 M | -37.9 M | 61.1 M |
Total Shareholders Equity of other stocks in the Diagnostics research industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
56.1 M | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
27.5 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
422 M | - | - | $ 1.31 B | USA |
 |
Fulgent Genetics
FLGT
|
1.11 B | $ 19.5 | 7.5 % | $ 600 M | USA |
 |
Celcuity
CELC
|
101 M | $ 92.47 | 3.96 % | $ 4.32 B | USA |
|
Akumin
AKU
|
-48.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
20.6 M | $ 5.76 | 11.41 % | $ 7.66 M | USA |
 |
Castle Biosciences
CSTL
|
471 M | $ 21.6 | 5.93 % | $ 626 M | USA |
 |
Aspira Women's Health
AWH
|
-6.93 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-56 M | - | -61.36 % | $ 2.46 M | USA |
 |
Guardant Health
GH
|
-99.3 M | $ 133.06 | 4.75 % | $ 16.7 B | USA |
 |
Biocept
BIOC
|
8.86 M | - | -13.05 % | $ 7.29 M | USA |
 |
ICON Public Limited Company
ICLR
|
9.19 B | $ 152.8 | 6.18 % | $ 12 B |  Irlanda |
 |
CareDx, Inc
CDNA
|
303 M | $ 23.12 | 3.63 % | $ 1.23 B | USA |
 |
Illumina
ILMN
|
2.72 B | $ 168.06 | -1.68 % | $ 26 B | USA |
 |
Chembio Diagnostics
CEMI
|
17.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
3.44 M | - | - | $ 9.42 M |  Israel |
 |
Interpace Biosciences
IDXG
|
22.4 M | $ 1.79 | 2.29 % | $ 7.92 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
5.39 M | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
4.88 B | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
1.83 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
1.69 B | - | 0.12 % | $ 80.1 M | China |
 |
Mettler-Toledo International
MTD
|
-23.6 M | - | - | $ 24.3 B |  Schweiz |
 |
DermTech
DMTK
|
57.2 M | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
1.09 B | - | - | $ 6.94 B | USA |
 |
NeoGenomics
NEO
|
837 M | $ 11.31 | 11.54 % | $ 1.45 B | USA |
 |
Charles River Laboratories International
CRL
|
3.16 B | $ 185.79 | 3.29 % | $ 9.21 B | USA |
 |
Natera
NTRA
|
1.71 B | $ 222.1 | 4.84 % | $ 30.4 B | USA |
 |
Medpace Holdings
MEDP
|
459 M | $ 458.69 | 1.75 % | $ 13.2 B | USA |
 |
Exact Sciences Corporation
EXAS
|
2.4 B | - | - | $ 19.8 B | USA |
 |
National Research Corporation
NRC
|
14 M | $ 19.75 | 3.73 % | $ 442 M | USA |
 |
Myriad Genetics
MYGN
|
368 M | $ 4.69 | 6.59 % | $ 434 M | USA |
 |
Personalis
PSNL
|
261 M | $ 12.1 | 12.24 % | $ 1.08 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
11 B | $ 25.99 | 2.52 % | $ 24.6 B |  Niderland |
 |
Senseonics Holdings
SENS
|
61 M | $ 7.01 | 4.32 % | $ 293 M | USA |
 |
QIAGEN N.V.
QGEN
|
3.78 B | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
4.1 M | - | - | $ 4.94 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
8.62 B | $ 260.97 | 0.79 % | $ 21.7 B | USA |
 |
Twist Bioscience Corporation
TWST
|
473 M | - | - | $ 4.42 B | USA |
 |
Thermo Fisher Scientific
TMO
|
53.4 B | $ 482.03 | 1.7 % | $ 182 B | USA |
 |
Trinity Biotech plc
TRIB
|
-35.2 M | $ 0.68 | -2.4 % | $ 244 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
2.69 M | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
2.07 B | $ 9.12 | 3.52 % | $ 1.98 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
7.17 B | $ 196.12 | 1.27 % | $ 21.8 B | USA |
 |
Invitae Corporation
NVTA
|
102 M | - | - | $ 21.2 M | USA |
 |
Waters Corporation
WAT
|
2.56 B | $ 376.47 | -0.87 % | $ 22.4 B | USA |